Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Shares Cross Above Two Hundred Day Moving Average – Here’s What Happened

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS)’s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $22.84 and traded as high as $23.84. Fresenius Medical Care AG & Co. KGaA shares last traded at $23.73, with a volume of 490,927 shares traded.

Analyst Upgrades and Downgrades

FMS has been the subject of several recent research reports. Citigroup reiterated a “neutral” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research report on Friday, April 24th. Morgan Stanley restated an “underweight” rating on shares of Fresenius Medical Care AG & Co. KGaA in a research note on Wednesday, May 6th. Jefferies Financial Group raised Fresenius Medical Care AG & Co. KGaA from a “strong sell” rating to a “moderate sell” rating in a report on Friday, May 8th. Wall Street Zen cut Fresenius Medical Care AG & Co. KGaA from a “buy” rating to a “hold” rating in a research report on Saturday, May 9th. Finally, Weiss Ratings downgraded shares of Fresenius Medical Care AG & Co. KGaA from a “hold (c+)” rating to a “hold (c)” rating in a report on Thursday, May 7th. Four analysts have rated the stock with a Hold rating and five have given a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Strong Sell” and an average price target of $28.00.

Fresenius Medical Care AG & Co. KGaA Trading Up 1.5%

The company has a debt-to-equity ratio of 0.40, a current ratio of 1.20 and a quick ratio of 0.86. The stock has a market cap of $12.82 billion, a P/E ratio of 12.49, a PEG ratio of 4.22 and a beta of 0.80. The firm’s fifty day moving average price is $22.32 and its two-hundred day moving average price is $22.84.

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) last posted its quarterly earnings data on Tuesday, March 31st. The company reported $1.05 earnings per share (EPS) for the quarter. Fresenius Medical Care AG & Co. KGaA had a return on equity of 8.90% and a net margin of 4.88%.The company had revenue of $5.34 billion during the quarter. As a group, equities research analysts forecast that Fresenius Medical Care AG & Co. KGaA will post 2.24 EPS for the current year.

Fresenius Medical Care AG & Co. KGaA Increases Dividend

The firm also recently declared an annual dividend, which was paid on Monday, June 8th. Shareholders of record on Friday, May 22nd were issued a $0.8716 dividend. This represents a dividend yield of 402.0%. The ex-dividend date of this dividend was Friday, May 22nd. This is an increase from Fresenius Medical Care AG & Co. KGaA’s previous annual dividend of $0.79. Fresenius Medical Care AG & Co. KGaA’s payout ratio is 32.11%.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of FMS. EverSource Wealth Advisors LLC increased its position in shares of Fresenius Medical Care AG & Co. KGaA by 50.3% in the first quarter. EverSource Wealth Advisors LLC now owns 4,135 shares of the company’s stock worth $93,000 after purchasing an additional 1,383 shares during the last quarter. Royal Bank of Canada lifted its position in Fresenius Medical Care AG & Co. KGaA by 479.2% during the first quarter. Royal Bank of Canada now owns 216,861 shares of the company’s stock valued at $4,893,000 after purchasing an additional 179,418 shares during the last quarter. Quantinno Capital Management LP grew its stake in Fresenius Medical Care AG & Co. KGaA by 15.7% in the 1st quarter. Quantinno Capital Management LP now owns 341,343 shares of the company’s stock worth $7,701,000 after buying an additional 46,428 shares in the last quarter. Sei Investments Co. grew its stake in Fresenius Medical Care AG & Co. KGaA by 80.7% in the 1st quarter. Sei Investments Co. now owns 120,704 shares of the company’s stock worth $2,723,000 after buying an additional 53,922 shares in the last quarter. Finally, Cetera Investment Advisers increased its holdings in shares of Fresenius Medical Care AG & Co. KGaA by 76.7% in the 1st quarter. Cetera Investment Advisers now owns 15,917 shares of the company’s stock worth $359,000 after buying an additional 6,909 shares during the last quarter. Hedge funds and other institutional investors own 8.37% of the company’s stock.

Fresenius Medical Care AG & Co. KGaA Company Profile

Fresenius Medical Care AG & Co KGaA is the world’s largest integrated provider of products and services for individuals with renal diseases. The company’s primary business activities encompass the operation of dialysis clinics and the manufacture and distribution of dialysis equipment, dialysis machines, dialyzers, consumables and related therapies. Through its global network of clinics, Fresenius Medical Care delivers comprehensive kidney care, including hemodialysis and peritoneal dialysis treatments, patient education and support services.

In its products segment, the company designs and produces dialysis machines, water treatment systems and disposables such as high‐flux dialyzers and bloodlines.